COMPLEXATION STUDY OF GLIMEPIRIDE WITH Mg

نویسندگان

  • PRIYANKA A. SHAH
  • JAIVIK V. SHAH
  • MALLIKA SANYAL
  • PRANAV S. SHRIVASTAV
چکیده

Objective: The present work describes complexation study of sulfonylurea based drug, glimepiride with divalent metal ions (Mg2+, Ca2+, Cu2+and Zn2+ Methods: The stoichiometry of resulting metal ion-glimepiride complexes were ascertained by molar conductance vs. mole ratio of glimepiride/metal ion plots, Job’s method of continuous variation and liquid chromatography-mass spectrometric analysis. The values of enthalpy and entropy of complexation reactions in methanol were obtained from van’t Hoff plots. ) in methanol by conductometry, spectrophotometry and liquid chromatography-mass spectrometry. Results: The formation constants of 1:1 (M2+: glimepiride) complexes at different temperatures followed the order Mg2+>Cu2+>Zn2+>Ca2+ Conclusion: The stability of complexes increased with temperature suggesting endothermic nature of complexation reactions. The thermodynamic data showed that all the complexes formed were entropy stabilized and enthalpy destabilized. A good linear relationship between ∆H and T∆S values suggests existence of entropy–enthalpy compensation in the complexation of these four cations with glimepiride. by conductometry as well as spectrophotometry. High molar conductivities were observed for all the complexes indicating formation of charged complex and the results were supported by the presence of protonated precursor complex ions in the mass spectral study.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

In-vitro – In-vivo Characterization of ‎Glimepiride Lipid Nanoparticulates ‎Prepared by Combined Approach of ‎Precipitation and Complexation

Novel lipid nanoparticulates (NCs) were developed by a combined approach of precipitation and complexation with an aim to improve the solubility, stability and targeting efficiency of glimepiride (GLP). GLP NCs were prepared by precipitation process using PEG 20000 and further complexed with phospholipon90G (P90G). The NCs were evaluated for physicochemical characterization, such as drug lo...

متن کامل

Higher Risk of Hypoglycemia with Glimepiride Versus Vildagliptin in Patients with Type 2 Diabetes is not Driven by High Doses of Glimepiride: Divergent Patient Susceptibilities?

INTRODUCTION In a previously published study, vildagliptin showed a reduced risk of hypoglycemia versus glimepiride as add-on therapy to metformin at similar efficacy. Glimepiride was titrated from a starting dose of 2 mg/day to a maximum dose of 6 mg/day. It is usually assumed that the increased hypoglycemia with glimepiride was driven by the 6 mg/day dose; it was therefore of interest to asse...

متن کامل

Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)

OBJECTIVE To compare the effect of sitagliptin (100 mg) vs glimepiride (1-3 mg) as add-on therapy in Indian type 2 diabetes (T2DM) patients on treatment with insulin and metformin (SWIM study). RESEARCH DESIGN AND METHODS This 24-week, controlled, open-label study randomized T2DM patients (n = 440) receiving a stable dose of metformin and insulin combination therapy to sitagliptin (100 mg) or...

متن کامل

Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study

INTRODUCTION This study assessed the safety and efficacy of ertugliflozin (an oral sodium-glucose cotransporter 2 inhibitor) vs. glimepiride in patients with type 2 diabetes mellitus (T2DM) inadequately controlled on metformin. METHODS This phase III, double-blind, non-inferiority study (NCT01999218) randomized patients with HbA1c ≥ 7.0% and ≤ 9.0% on stable metformin ≥ 1500 mg/day 1:1:1 to e...

متن کامل

Efficacy of Combination Therapy With Sitagliptin and Low-Dose Glimepiride in Japanese Patients With Type 2 Diabetes

BACKGROUND We examined the effects of combination therapy with 50 mg/day of sitagliptin and low-dose glimepiride (1 mg/day) in patients with type 2 diabetes. METHODS Twenty-six patients with poorly controlled type 2 diabetes currently taking high-dose glimepiride (≥ 2 mg/day) were enrolled in the study. The dose of glimepiride was reduced to 1 mg/day and 50 mg/day of sitagliptin was added wit...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2015